Medeze Group PCL (BKK:MEDEZE)

Medeze Group PCL Revenue

Medeze Group PCL had revenue of 170.31M THB in the quarter ending June 30, 2026, a decrease of -13.83%. This brings the company's total for the last twelve months to 714.44M, down -18.33% year-over-year. In the year 2025, Medeze Group PCL had annual revenue of 776.41M, down -11.15%. That makes Medeze Group PCL the 33,485th largest company in the world by revenue and 678th in Thailand.

• Revenue (ttm): 714.44M
• Revenue Growth: -18.33%
• P/S Ratio: 8.97
• Revenue / Employee: 3.57M
• Employees: 200
• Market Cap: 6.41B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Stem Cells Sample Collection, Sorting and Cultivation - Placenta 363.40M 44.3%
• Stem Cells Sample Collection, Sorting and Cultivation - Adipose Tissue 130.01M 15.9%
• Natural Killer Cells - Testing Services 116.88M 14.3%
• Other Services 97.26M 11.9%
• Stem Cells Sample Collection, Sorting and Cultivation - Cord Blood 58.90M 7.2%
• Unallocated Other Income 32.76M 4.0%
• Stem Cells Sample Collection, Sorting and Cultivation - Hair Follicle 13.57M 1.7%
• Sales of Products 7.37M 0.9%

By Geography

Chart

• Thailand 634.02M 85.3%
• Philippines 48.85M 6.6%
• Vietnam 26.01M 3.5%
• Other Countries 20.81M 2.8%
• Cambodia 13.96M 1.9%

Fiscal year ended Dec 31, 2025 See the full Medeze Group PCL breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	776.41M	-97.46M	-11.15%
Dec 31, 2024	873.87M	166.51M	23.54%
Dec 31, 2023	707.37M	95.39M	15.59%
Dec 31, 2022	611.98M	147.68M	31.81%
Dec 31, 2021	464.29M	57.06M	14.01%

Data Source: S&P Global Market Intelligence Last updated: Aug 11, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error